Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LGALS7 Antikörper (AA 54-82)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch LGALS7 in WB. Er zeigt eine Reaktivität gegenüber Human und wurde in 4+ Publikationen erwähnt.
Produktnummer ABIN1881493

Kurzübersicht für LGALS7 Antikörper (AA 54-82) (ABIN1881493)

Target

Alle LGALS7 Antikörper anzeigen
LGALS7 (Galectin 7 (LGALS7))

Reaktivität

  • 71
  • 40
  • 29
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 92
  • 22
  • 1
Kaninchen

Klonalität

  • 83
  • 32
Polyklonal

Konjugat

  • 44
  • 19
  • 15
  • 6
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser LGALS7 Antikörper ist unkonjugiert

Applikation

  • 78
  • 43
  • 28
  • 27
  • 18
  • 14
  • 14
  • 9
  • 8
  • 7
  • 4
  • 4
  • 4
Western Blotting (WB)

Klon

RB31765
  • Bindungsspezifität

    • 23
    • 15
    • 14
    • 7
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 54-82

    Aufreinigung

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This LGALS7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 54-82 amino acids from the Central region of human LGALS7.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Demers, Rose, Grosset, Biron-Pain, Gaboury, Siegel, St-Pierre: "Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells." in: The American journal of pathology, Vol. 176, Issue 6, pp. 3023-31, (2010) (PubMed).

    Park, Chang, Cho: "Induction of matrix metalloproteinase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells." in: Oncology reports, Vol. 22, Issue 6, pp. 1373-9, (2009) (PubMed).

    Demers, Couillard, Giglia-Mari, Magnaldo, St-Pierre: "Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation." in: Biochemical and biophysical research communications, Vol. 387, Issue 3, pp. 425-9, (2009) (PubMed).

    Saussez, Cludts, Capouillez, Mortuaire, Smetana, Kaltner, André, Leroy, Gabius, Decaestecker: "Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7." in: International journal of oncology, Vol. 34, Issue 2, pp. 433-9, (2009) (PubMed).

  • Target

    LGALS7 (Galectin 7 (LGALS7))

    Andere Bezeichnung

    LGALS7

    Hintergrund

    The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Differential and in situ hybridization studies indicate that this lectin is specifically expressed in keratinocytes and found mainly in stratified squamous epithelium. A duplicate copy of this gene (GeneID:653499) is found adjacent to, but on the opposite strand on chromosome 19.

    Molekulargewicht

    15075

    NCBI Accession

    NP_001035972, NP_002298

    UniProt

    P47929
Sie sind hier:
Chat with us!